Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Biological Chemistry

• Publication date

  1999-02-12

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/JBC.274.7.4421PMID 9933646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix degrading metalloproteinases

  2005cited by this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cited by this paper
• Crystal structure of the complex formed by the membrane type 1‐matrix metalloproteinase with the tissue inhibitor of metalloproteinases‐2, the soluble progelatinase A receptor

  1998cited by this paper
• The Involvement of the Fibronectin Type II-like Modules of Human Gelatinase A in Cell Surface Localization and Activation*

  1998cited by this paper
• Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP)*

  1998cited by this paper
• The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.

  1998cited by this paper
• Kinetic Analysis of the Binding of Human Matrix Metalloproteinase-2 and -9 to Tissue Inhibitor of Metalloproteinase (TIMP)-1 and TIMP-2*

  1997cited by this paper
• Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.

  1997cited by this paper
• The Hemopexin-like Domain (C Domain) of Human Gelatinase A (Matrix Metalloproteinase-2) Requires Ca2+ for Fibronectin and Heparin Binding

  1997cited by this paper
• Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.

  1997cited by this paper
• Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A

  1997cited by this paper
• A myoglobin variant with a polar substitution in a conserved hydrophobic cluster in the heme binding pocket.

  1997cited by this paper
• Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

  1997cited by this paper
• The Activation, Expression and Function of Gelatinase A (MMP-2)

  1996cited by this paper
• Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3

  1996cited by this paper
• Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4*

  1996cited by this paper
• Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

  1996cited by this paper
• The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation

  1996cited by this paper
• The C‐terminal (haemopexin‐like) domain structure of human gelatinase A (MMP2): structural implications for its function

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.

  1995cited by this paper
• Crystal structure of the haemopexin-like C-terminal domain of gelatinase A

  1995cited by this paper
• Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).

  1995cited by this paper
• Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin.

  1995cited by this paper
• Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism (*)

  1995cited by this paper
• Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen

  1995cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.

  1994cited by this paper
• Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.

  1993cited by this paper
• The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

  1993cited by this paper
• Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain.

  1993cited by this paper
• The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

  1992cited by this paper
• The matrix‐degrading metalloproteinases

  1992cited by this paper
• Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

  1992cited by this paper
• Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.

  1991cited by this paper
• Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site.

  1991cited by this paper
• Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

  1991cited by this paper
• Recent Advances in Matrix Metalloproteinase Research

  1991cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.

  1989cited by this paper
• Fast and sensitive multiple sequence alignments on a microcomputer

  1989cited by this paper
• Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

  1989cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1987cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper
• Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization.

  1983cited by this paper
• Purification of rabbit bone inhibitor of collagenase.

  1981cited by this paper

• Interaction of Drug-Sensitive and -Resistant Human Melanoma Cells with HUVEC Cells: A Label-Free Cell-Based Impedance Study

  2023influential citation
• Functional Expression and Purification of the Untagged C-terminal Domain of MMP-2 from Escherichia coli Inclusion Bodies.

  2020cites this paper
• The epitope-mediated MMP activation assay: detection and quantification of the activation of Mmp2 in vivo in the zebrafish embryo

  2018cites this paper
• An epitope-tagged reporter to detect MMP activation in vivo: Mmp2 activation patterns reveal Mmp14-independent regulation in zebrafish embryos

  2017cites this paper
• New intracellular activities of matrix metalloproteinases shine in the moonlight.

  2017cites this paper
• Matrix metalloproteinase-2 and -9 in the cerebellum of teleost fish: Functional implications for adult neurogenesis.

  2015cites this paper
• Proteolysis during Tumor Cell Extravasation In Vitro: Metalloproteinase Involvement across Tumor Cell Types

  2013cites this paper
• Advances in Protein Chemistry

  2013cites this paper
• Matrix Metallopeptidase-2/Gelatinase A

  2013cites this paper
• The Role of Matrix Metalloproteinase-2 in the Pathophysiology of a Reduced Utero-Placental Perfusion Pressure Model of Preeclampsia

  2012cites this paper
• The gelatinases and their inhibitors: the structure-activity relationships.

  2012cites this paper
• Peptide from the C-terminal domain of tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) inhibits membrane activation of matrix metalloproteinase-2 (MMP-2).

  2011influential citation
• Aberrant Signalling Complexes in GBMs: Prognostic and Therapeutic Implications

  2010cites this paper
• Prostaglandin E 2 receptor subtype EP 2-and EP 4-regulated gene expression profiling in human ciliary smooth muscle cells

  2010cites this paper
• Prostaglandin E2 receptor subtype EP2- and EP4-regulated gene expression profiling in human ciliary smooth muscle cells.

  2010cites this paper
• Tissue Inhibitor of Metalloproteinase-2 Regulates Matrix Metalloproteinase-2–Mediated Endothelial Barrier Dysfunction and Breast Cancer Cell Transmigration through Lung Microvascular Endothelial Cells

  2010cites this paper
• The hemopexin domain of MMP‐9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice

  2009cites this paper
• A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects

  2009cites this paper
• Metalloproteinase cleavage of versican at the fibroblast cell surface

  2009cites this paper
• Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation

  2009cites this paper
• Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.

  2008cites this paper
• Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.

  2008cites this paper
• Quantitative Degradomics Analysis of Proteolytic Post-Translational Modifications of the

  2008cites this paper
• Metadegradomics

  2008cites this paper
• Immunohistochemical study of Matrix Metalloproteinase - 1 (MMP-1) expression in Oral Submucous Fibrosis

  2007cites this paper
• Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins

  2007cites this paper
• InteractionbetweenCancerCells andStromalFibroblasts IsRequiredforActivationof theuPAR-uPA-MMP-2 CascadeinPancreaticCancerMetastasis

  2007cites this paper
• Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis

  2006cites this paper
• TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains*

  2006cites this paper
• Structural characterization and binding properties of the hemopexin-like domain of the matrixmetalloproteinase-19.

  2006cites this paper
• Cell-Surface Association between Progelatinases and beta² Integrins: Role of the Complexes in Leukocyte Migration

  2006cites this paper
• Pancreatic trypsin activates human promatrix metalloproteinase-2.

  2005cites this paper
• Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.

  2005cites this paper
• Gold nanoparticle-enhanced surface plasmon resonance measurement with a highly sensitive quantification for human tissue inhibitor of metalloproteinases-2

  2005cites this paper
• The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

  2005cites this paper
• Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo

  2005cites this paper
• Recombinant interferon-γ secreted by chinese hamster ovary-320 cells cultivated in suspension in protein-free media is protected against extracellular proteolysis by the expression of natural protease inhibitors and by the addition of plant protein hydrolysates to the culture medium

  2005cites this paper
• Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation*

  2004cites this paper
• Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera

  2004cites this paper
• Angiogenesis and invasion in gliomas.

  2004cites this paper
• The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.

  2004cites this paper
• Characterization of the Distinct Collagen Binding, Helicase and Cleavage Mechanisms of Matrix Metalloproteinase 2 and 14 (Gelatinase A and MT1-MMP)

  2004cites this paper
• Detection of subpicomolar concentrations of human matrix metalloproteinase-2 by an optical biosensor.

  2004cites this paper
• The Canonical Methionine 392 of Matrix Metalloproteinase 2 (Gelatinase A) Is Not Required for Catalytic Efficiency or Structural Integrity

  2004cites this paper
• Glycosylation Broadens the Substrate Profile of Membrane Type 1 Matrix Metalloproteinase*

  2004cites this paper
• The TIMPs tango with MMPs and more in the central nervous system

  2004cites this paper
• 129 – Gelatinase A

  2004cites this paper
• Aggrecan degradation in health and disease

  2004cites this paper
• Kinetic Analysis of the Binding of Hemopexin-Like Domain of Gelatinase B Cloned and Expressed in Pichia pastoris to Tissue Inhibitor of Metalloproteinases-1

  2003cites this paper
• Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

  2003cites this paper
• Prolonged Spinal Loading Induces Matrix Metalloproteinase-2 Activation in Intervertebral Discs

  2003cites this paper
• Matrix metalloproteinases and tumor progression.

  2003cites this paper
• TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.

  2003cites this paper
• Matrix metalloproteinase inhibitors--an emphasis on gastrointestinal malignancies.

  2003cites this paper
• Proteolytic host cell enzymes in gingival crevice fluid.

  2003cites this paper
• The Possible Role of Matrix Metalloproteinase (mmp)-2 and Mmp-9 in Cancer, E.g. Acute Leukemia

  2003cites this paper
• Sequence Specific Biotinylation and Purification of Proteins Expressed in the RTS 500 System

  2002cites this paper
• Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics

  2002cites this paper
• Gelatin Zymography and Substrate Cleavage Assays of Matrix Metalloproteinase-2 in Breast Carcinoma Cells Overexpressing Membrane Type-1 Matrix Metalloproteinase

  2002cites this paper
• Strategies for MMP inhibition in cancer: innovations for the post-trial era

  2002cites this paper
• Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene.

  2002cites this paper
• Calcium Regulation of Matrix Metalloproteinase-mediated Migration in Oral Squamous Cell Carcinoma Cells*

  2002cites this paper
• Proteases and Their Inhibitors in Cancer Metastasis

  2002cites this paper
• Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: A New Tool for Degradomics

  2002cites this paper
• Punctin, a Novel ADAMTS-like Molecule, ADAMTSL-1, in Extracellular Matrix*

  2002cites this paper
• Structural basis of the adaptive molecular recognition by MMP9.

  2002cites this paper
• Membrane-type-1 matrix metalloproteinase in pericellular proteolysis and cell migration

  2002influential citation
• Matrix-directed regulation of pericellular proteolysis and tumor progression.

  2002cites this paper
• Utilization of a Novel Recombinant Myoglobin Fusion Protein Expression System to Characterize the Tissue Inhibitor of Metalloproteinase (TIMP)-4 and TIMP-2 C-terminal Domain and Tails by Mutagenesis

  2002cites this paper
• Molecular determinants of metalloproteinase substrate specificity

  2002cites this paper
• Tissue Inhibitors of Metalloproteinases in Cancer

  2002cites this paper
• The Gelatinases, MMP-2 and MMP-9-Implications for Invasion and Metastasis

  2002cites this paper
• Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2

  2002cites this paper
• Effects of mechanical stretching on trabecular matrix metalloproteinases.

  2001cites this paper
• Hemopexin: a review of biological aspects and the role in laboratory medicine.

  2001cites this paper
• Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway*

  2001cites this paper
• Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.

  2001cites this paper
• Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.

  2001cites this paper
• Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.

  2001cites this paper
• Matrix MetaIIoproteinase Substrate Binding Domains, Modules and Exosites

  2001cites this paper
• The matrix metalloproteinase gelatinase A in human dentine.

  2000cites this paper
• The Tissue Inhibitors of Metalloproteinases (TIMPs): Biology and Regulation

  2000cites this paper
• Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.

  2000cites this paper
• Domain Interactions in the Gelatinase A·TIMP-2·MT1-MMP Activation Complex

  2000cites this paper
• TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo *

  2000cites this paper
• Structure and function of procollagen C-proteinase (mTolloid) domains determined by protease digestion, circular dichroism, binding to procollagen type I, and computer modeling.

  2000cites this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cites this paper
• Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.

  1999cites this paper